Benzinga | Dec 7, 2021 08:28AM EST

Morgan Stanley Maintains Equal-Weight on Core Laboratories, Lowers Price Target to $32

Morgan Stanley analyst Connor Lynagh maintains Core Laboratories (NYSE:CLB) with a Equal-Weight and lowers the price target from $34 to $32.